Business Daily meets: Fintech founder Upasana...

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

On today’s episode of McKinsey on Startups, we talk to Adeyemi Ajao, the cofounder and Managing Partner at Base 10 Partners. The San Francisco-based VC firm focuses on startups bringing automation technology to a variety of sectors in what it calls the Real Economy, including log ...  Show more

On today’s episode of McKinsey on Startups, we talk to Gautam Nadella, an operating partner at EQT Ventures in the Bay Area, where he drives M&A, fundraising, and partnership efforts within their portfolio of more than 100 companies. EQT invests in a wide range of companies in bo ...  Show more

McKinsey innovation leader Erik Roth speaks with Shiprocket cofounder and CEO <a href="https://www.linkedin.com/in/saahilgoel?originalSubd ...

In India, the government is ready to implement or give leverage blockchain technology but alarmed of cryptocurrencies. India always being known for it's growing IT industries. Even when we talk about blockchain, Blockchain projects are creating new job categories, leading to hiri ...  Show more